Diseases of the Liver

  • Michael L. Parchman


The liver is vulnerable to injury from viral agents and to exposure to ingested and inhaled toxins. The usual result of injury is an inflammatory reaction known as hepatitis. Hepatitis may be classified as acute or chronic.


Spontaneous Bacterial Peritonitis Acute Viral Hepatitis Immune Serum Globulin Icteric Phase 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Lednar WM, Lemon SM, Kirkpatrick JW, et al. Frequency of illness associated with epidemic hepatitis A virus infections in adults. Am J Epidemiol 1985;122:226–33.PubMedGoogle Scholar
  2. 2.
    Mclntyre M. Clinical presentation of acute viral hepatitis. Br Med Bull 1990;46:533–47.Google Scholar
  3. 3.
    Tozan N, Forbes A, Anderson MG, Murray-Lyon IM. Safety of alcohol consumption after acute viral hepatitis. Lancet 1991;337:1079–80.CrossRefGoogle Scholar
  4. 4.
    Farero MS, Maynard JE, Leger RT, et al. Guidelines for the care of patients hospitalized with viral hepatitis. Ann Intern Med 1979;91:872–4.CrossRefGoogle Scholar
  5. 5.
    Shapiro CN. Epidemiology of hepatitis B. Pediatr Infect Dis J 1993;12:433–7.PubMedCrossRefGoogle Scholar
  6. 6.
    McMahon BJ, Alward WLM, Hall BD, et al. Acute hepatitis B infection: relation of age to the clinical expression of disease and subsequent development of the carrier state. J Infect Dis 1985;151:599–603.PubMedCrossRefGoogle Scholar
  7. 7.
    Bacon BR. Managing chronic hepatitis: recent advances in diagnosis and treatment. Postgrad Med 1991;90:103–12.PubMedGoogle Scholar
  8. 8.
    Choo QL, Weiner AJ, Overby LR, et al. Hepatitis C virus: the major causative agent of viral non-A, non-B hepatitis. Br Med Bull 1990;46:423–41.PubMedGoogle Scholar
  9. 9.
    Alter MJ. The detection, transmission and outcome of hepatitis C virus infection. Infect Agents Dis 1993;2:155–66.PubMedGoogle Scholar
  10. 10.
    Esteban JI, Esteban R, Viladomiu L, et al. Hepatitis C virus antibodies among risk groups in Spain. Lancet 1989;2:294–7.PubMedCrossRefGoogle Scholar
  11. 11.
    Lynch-Salamon DI, Combs CA. Hepatitis C in obstetrics and gynecology. Obstet Gynecol 1992;79:621–9.PubMedGoogle Scholar
  12. 12.
    Alter HJ, Purcell RH, Shih JW, et al. Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis. N Engl J Med 1989;321:1494–500.PubMedCrossRefGoogle Scholar
  13. 13.
    Williams AE, Dodd RY. The serology of hepatitis C virus in relation to posttransfusion hepatitis. Ann Clin Lab Sci 1990; 20:192–9.Google Scholar
  14. 14.
    Koretz RL, Stone O, Gitnick GI. The long-term course of non-A, non-B posttransfusion hepatitis. Gastroenterology 1980;79:893–8.PubMedGoogle Scholar
  15. 15.
    Holt DA, Baran DA, Ochler RL, Sinnott IV. Delta hepatitis: a diagnostic algorithm. Infect Med 1993;10:23–9.Google Scholar
  16. 16.
    Kools AM. Hepatitis A, B, C, D and E: update on testing and treatment. Postgrad Med 1992;91:109–14.PubMedGoogle Scholar
  17. 17.
    Davis GL, Baiart LA, Schiff ER, et al. Treatment of chronic hepatitis C with recombinant interferon alpha: a multicenter randomized, controlled trial. N Engl J Med 1989;321:1501–6.PubMedCrossRefGoogle Scholar
  18. 18.
    Korenman J, Baker B, Waggoner J, et al. Long term remission of chronic hepatitis B after alpha-interferon therapy. Ann Intern Med 1991;114:629–34.PubMedCrossRefGoogle Scholar
  19. 19.
    Centers for Disease Control. Protection against viral hepatitis: recommendations of the Immunization Practices Advisory Committee (ACIP). MMWR 1990;39:(RR-2):l–26.Google Scholar
  20. 20.
    Noskin GA. Prevention, diagnosis and management of viral hepatitis A guide for primary care physicians. Arch Fam Med 1995;4:923–34.PubMedCrossRefGoogle Scholar
  21. 21.
    Alter MJ, Hadler SC, Margolis HS, et al. The changing epidemiology of hepatitis B in the United States: the need for alternative vaccinations strategies. JAMA 1990;263:1218–22.PubMedCrossRefGoogle Scholar
  22. 22.
    Centers for Disease Control. Hepatitis B virus: a comprehensive strategy for eliminating transmission in the United States through universal childhood vaccination. MMWR 1991; 40(RR-13):1–19.Google Scholar
  23. 23.
    Lieber CS. Biochemical and molecular basis of alcohol-induced injury to liver and other tissues. N Engl J Med 1988; 319:1639–50.PubMedCrossRefGoogle Scholar
  24. 24.
    Sorensen TIA, Orholm M, Bensten KD, et al. Prospective evaluation of alcohol abuse and alcoholic liver disease in men as predictors of development of cirrhosis. Lancet 1984; 1:241–3.CrossRefGoogle Scholar
  25. 25.
    Norton R, Batey R, Dwyer R, MacMahon S. Alcohol consumption and the risk of alcohol-related cirrhosis in women. BMJ 1987;295:80–2.PubMedCrossRefGoogle Scholar
  26. 26.
    Grant BF, Dufour MC, Harford TC. Epidemiology of alcoholic liver disease. Semin Liver Dis 1988;8:12–15.PubMedCrossRefGoogle Scholar
  27. 27.
    Lee WM. Drug-induced hepatotoxicity. N Engl J Med 1995; 333:1118–27.PubMedCrossRefGoogle Scholar
  28. 28.
    Duscheiko GM. Hepatocellular carcinoma associated with chronic viral hepatitis: aetiology, diagnosis and treatment. Br Med Bull 1990;46:492–511.Google Scholar
  29. 29.
    Simonetti RG, Calogero C, Fiorello F, et al. Hepatitis C virus infection as a risk factor for hepatocellular carcinoma in patients with cirrhosis. Ann Intern Med 1992;116:97–102.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1998

Authors and Affiliations

  • Michael L. Parchman

There are no affiliations available

Personalised recommendations